NO20081481L - Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning - Google Patents
Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivningInfo
- Publication number
- NO20081481L NO20081481L NO20081481A NO20081481A NO20081481L NO 20081481 L NO20081481 L NO 20081481L NO 20081481 A NO20081481 A NO 20081481A NO 20081481 A NO20081481 A NO 20081481A NO 20081481 L NO20081481 L NO 20081481L
- Authority
- NO
- Norway
- Prior art keywords
- pharmaceutical composition
- controlled release
- composition containing
- containing carvedilol
- carvedilol
- Prior art date
Links
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical compound COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004195 carvedilol Drugs 0.000 title abstract 3
- 238000013270 controlled release Methods 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 239000010410 layer Substances 0.000 abstract 3
- 239000002702 enteric coating Substances 0.000 abstract 2
- 238000009505 enteric coating Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 239000000853 adhesive Substances 0.000 abstract 1
- 230000001070 adhesive effect Effects 0.000 abstract 1
- 150000007524 organic acids Chemical class 0.000 abstract 1
- 239000008188 pellet Substances 0.000 abstract 1
- 229920000642 polymer Polymers 0.000 abstract 1
- 239000007787 solid Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
- A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Chemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Foreliggende oppfinnelse relaterer til en kontrollert frigivning farmasøytisk sammensetning i en sjikt pellet form inneholdende karvedilol. Sammensetningen inneholder en kjerne inneholdende en fast organisk syre, et enterisk beleggsjikt på kjernen, et sjikt inneholdende karvedilol og et vannoppløselig adhesiv på overflaten av det enteriske belegg, og et oppløsningskontrollerende sjikt inneholdende en blanding av vannoppløselige og enteriske polymerer.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
HU0500803A HU227490B1 (en) | 2005-08-26 | 2005-08-26 | Sustained release pharmaceutical preparation containing carvedilol |
PCT/HU2006/000068 WO2007023325A2 (en) | 2005-08-26 | 2006-08-23 | Controlled release pharmaceutical composition containing carvedilol |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20081481L true NO20081481L (no) | 2008-05-19 |
Family
ID=89986232
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20081481A NO20081481L (no) | 2005-08-26 | 2008-03-26 | Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning |
Country Status (11)
Country | Link |
---|---|
EP (1) | EP1928431B8 (no) |
AT (1) | ATE418969T1 (no) |
DE (1) | DE602006004610D1 (no) |
DK (1) | DK1928431T3 (no) |
EA (1) | EA013058B1 (no) |
ES (1) | ES2321980T3 (no) |
HU (1) | HU227490B1 (no) |
NO (1) | NO20081481L (no) |
PL (1) | PL1928431T3 (no) |
PT (1) | PT1928431E (no) |
WO (1) | WO2007023325A2 (no) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA78974C2 (en) | 2001-10-20 | 2007-05-10 | Boehringer Ingelheim Pharma | Use of flibanserin for treating disorders of sexual desire |
US10675280B2 (en) | 2001-10-20 | 2020-06-09 | Sprout Pharmaceuticals, Inc. | Treating sexual desire disorders with flibanserin |
ES2646326T3 (es) | 2005-08-03 | 2017-12-13 | Sprout Pharmaceuticals, Inc. | Uso de flibanserina en el tratamiento de la obesidad |
CA2626134C (en) | 2005-10-29 | 2013-12-24 | Boehringer Ingelheim International Gmbh | Benzimidazolone derivatives for the treatment of premenstrual and other female sexual disorders |
DE602007004615D1 (de) | 2006-06-30 | 2010-03-18 | Boehringer Ingelheim Pharma | Flibanserin zur behandlung von harninkontinenz und assoziierten erkrankungen |
AR062320A1 (es) | 2006-08-14 | 2008-10-29 | Boehringer Ingelheim Int | Formulaciones de flibanserina y metodo para fabricarlas |
EA200900270A1 (ru) | 2006-08-25 | 2009-08-28 | Бёрингер Ингельхайм Интернациональ Гмбх | Системы регулируемого высвобождения и способ их приготовления |
HU227881B1 (en) * | 2007-02-23 | 2012-05-29 | Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag | Sustained release pharmaceutical preparation containing carvedilol |
CL2008002693A1 (es) | 2007-09-12 | 2009-10-16 | Boehringer Ingelheim Int | Uso de flibanserina para el tratamiento de sintomas vasomotores seleccionados de sofocos, sudores nocturnos, cambios de estado de animo e irritabilidad |
CN101801357B (zh) | 2007-09-21 | 2013-08-07 | 赢创罗姆有限公司 | 耐受乙醇的影响的pH依赖性受控释放的药物组合物 |
WO2009047800A2 (en) * | 2007-10-09 | 2009-04-16 | Lupin Limited | Oral controlled release composition of carvedilol |
US8133506B2 (en) * | 2008-03-12 | 2012-03-13 | Aptalis Pharmatech, Inc. | Drug delivery systems comprising weakly basic drugs and organic acids |
CN103099793B (zh) * | 2013-02-06 | 2015-07-15 | 中国人民解放军第二军医大学 | 片剂及其制备方法 |
JP7336187B2 (ja) | 2017-11-30 | 2023-08-31 | 日本ケミファ株式会社 | 多層構造を有する粒子状医薬組成物 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2004518734A (ja) * | 2000-10-24 | 2004-06-24 | スミスクライン・ビーチャム・コーポレイション | カルベジロールの新規処方 |
DE10209982A1 (de) * | 2002-03-07 | 2003-09-25 | Boehringer Ingelheim Pharma | Oral zu applizierende Darreichungsform für schwerlösliche basische Wirkstoffe |
AU2003288608A1 (en) * | 2002-12-20 | 2004-07-14 | Ranbaxy Laboratories Limited | Controlled release, multiple unit drug delivery systems |
-
2005
- 2005-08-26 HU HU0500803A patent/HU227490B1/hu not_active IP Right Cessation
-
2006
- 2006-08-23 EP EP06779688A patent/EP1928431B8/en active Active
- 2006-08-23 EA EA200800666A patent/EA013058B1/ru not_active IP Right Cessation
- 2006-08-23 PL PL06779688T patent/PL1928431T3/pl unknown
- 2006-08-23 DK DK06779688T patent/DK1928431T3/da active
- 2006-08-23 AT AT06779688T patent/ATE418969T1/de active
- 2006-08-23 ES ES06779688T patent/ES2321980T3/es active Active
- 2006-08-23 DE DE602006004610T patent/DE602006004610D1/de not_active Expired - Fee Related
- 2006-08-23 WO PCT/HU2006/000068 patent/WO2007023325A2/en active Application Filing
- 2006-08-23 PT PT06779688T patent/PT1928431E/pt unknown
-
2008
- 2008-03-26 NO NO20081481A patent/NO20081481L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2007023325A2 (en) | 2007-03-01 |
ES2321980T3 (es) | 2009-06-15 |
EA013058B1 (ru) | 2010-02-26 |
ATE418969T1 (de) | 2009-01-15 |
DE602006004610D1 (de) | 2009-02-12 |
PT1928431E (pt) | 2009-03-25 |
HU227490B1 (en) | 2011-07-28 |
EP1928431A2 (en) | 2008-06-11 |
HUP0500803A2 (en) | 2007-05-29 |
EP1928431B8 (en) | 2009-04-08 |
DK1928431T3 (da) | 2009-04-20 |
EP1928431B1 (en) | 2008-12-31 |
HUP0500803A3 (en) | 2008-03-28 |
PL1928431T3 (pl) | 2009-07-31 |
WO2007023325A3 (en) | 2007-06-28 |
EA200800666A1 (ru) | 2008-06-30 |
HU0500803D0 (en) | 2005-11-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20081481L (no) | Farmasoytisk sammensetning inneholdende carvedilol, med regulert frigivning | |
WO2011063089A3 (en) | Surface-modified adhesives | |
MX2012008908A (es) | Pelicula que se puede rotular con laser resistente al calor. | |
WO2008132045A3 (en) | Substrates with biocidal coating | |
WO2010017558A3 (en) | Composite material compositions and methods | |
EP2236283A4 (en) | MEMBERS WITH A CORROSION-RESISTANT COATING FILM, METHOD FOR THE PRODUCTION THEREOF AND COATING COMPOSITION FOR THE PRODUCTION THEREOF | |
WO2011060256A3 (en) | Bilayer tablet formulations | |
ATE538185T1 (de) | Laserempfindliche beschichtungszusammensetzung | |
BR112012013076A2 (pt) | processo para revestir substratos cerâmicos, e, substrato cerâmico. | |
WO2008115890A3 (en) | Mapk/erk kinase inhibitors | |
WO2010112358A3 (de) | Verfahren zur beschichtung einer oberfläche eines bauteils | |
MX2012000656A (es) | Materiales de componentes multiples que tienen una composicion que cambia de color. | |
WO2012163678A3 (de) | Verfahren zur herstellung geschäumter tapeten | |
TW201129652A (en) | Novel use of lipolytic enzyme for formation of anti-fingerprint coating, method of forming anti-fingerprint coating, substrate comprising the anti-fingerprint coating formed by the method, and product comprising the substrate | |
MX2010010053A (es) | Granulos. | |
WO2010029331A3 (en) | Colour forming composition | |
WO2011007285A3 (en) | Multiple component materials having a color-changing composition | |
AR053143A1 (es) | Metodo para preparar un sustrato revestido y sustratos obtenidos | |
WO2008139136A3 (en) | Sensor coating | |
IN2013DN02545A (no) | ||
TW200631791A (en) | Self-adhesive laminate | |
CL2008002551A1 (es) | Aducto amina-funcional; composicion curable, multicomponentes ; sustrato recubierto con dicha composicion; y procedimiento para proveer un recubrimiento a un sustrato | |
JP2009007185A5 (no) | ||
WO2017123381A3 (en) | Antifog coating composition and method of making thereof | |
WO2008092649A3 (de) | Farbige markierung und beschriftung mittels energiereicher strahlung |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |